These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2462283)

  • 21. [Modification of the autonomic vascular reaction and peripheral circulation in the handgrip and orthostasis test by beta-blockage in patients with and without peripheral arterial occlusive disease].
    Valentin A; Karnik R; Kaspar L; Slany J
    Vasa Suppl; 1988; 26():220-2. PubMed ID: 2974186
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapy of arterial occlusive diseases. The effect of bencyclan in trained patients with peripheral arterial occlusive disease (Double-blind study)].
    Battke K; Buchwalsky R; Barmeyer J; Hoffmann G; Reindell H
    Fortschr Med; 1978 Jul; 96(26-27):1381-6. PubMed ID: 669532
    [No Abstract]   [Full Text] [Related]  

  • 23. [Autotransfusion with leap-frog technique in patients with coronary heart disease and planned aortocoronary venous bypass].
    Kiesewetter H; Jung F; Pindur G; Koscielny J; Jakobs K; Wenzel E
    Infusionsther Transfusionsmed; 1994 Apr; 21(2):96-103. PubMed ID: 7517239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
    Angelkort B
    Wien Med Wochenschr; 1986; 136 Spec No():29-35. PubMed ID: 3548089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness of intravenous infusion treatment of peripheral arterial occlusive disease with Trental--results of a multicenter double-blind study].
    Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ; Rössner M
    Vasa Suppl; 1987; 20():375-8. PubMed ID: 3321494
    [No Abstract]   [Full Text] [Related]  

  • 26. [Conservative therapy of peripheral arterial occlusive diseases].
    Alexander K
    Z Kardiol; 1993; 82 Suppl 5():89-98. PubMed ID: 8154166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Induced hemodilution as a new concept in the therapy of peripheral circulatory disorders].
    Rieger H
    Internist (Berl); 1982 Jul; 23(7):375-82. PubMed ID: 7049999
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hemodilution therapy in peripheral arterial occlusive disease].
    Internist (Berl); 1992 May; 33(5 Suppl [HAMODILU]):1-8. PubMed ID: 1618610
    [No Abstract]   [Full Text] [Related]  

  • 29. [Peripheral arterial occlusive disease--initial therapy in general practice].
    Klimm HD
    Fortschr Med; 1993 Apr; 111(11):181-2. PubMed ID: 8508993
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of acute normovolemic hemodilution and acute hypervolemic hemodilution on coagulation and allogeneic transfusion.
    Saricaoglu F; Akinci SB; Celiker V; Aypar U
    Saudi Med J; 2005 May; 26(5):792-8. PubMed ID: 15951872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hemodilution in patients with stage IIb peripheral arterial occlusive disease: prospective randomized double-blind comparison of middle-molecular weight hydroxyethyl starch and low-molecular weight dextran solution].
    Kiesewetter H; Jung F; Blume J; Gerhards M
    Klin Wochenschr; 1987 Apr; 65(7):324-30. PubMed ID: 2438451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemorheologic and clinical in vitro and in vivo studies of the effectiveness of isovolemic hemodilution using Gelafusal and Infukoll M40 in patients with peripheral arterial occlusive disease].
    Pöhlmann G; Braumann A; Grohmann G
    Vasa Suppl; 1991; 32():342-4. PubMed ID: 1722914
    [No Abstract]   [Full Text] [Related]  

  • 33. [Ambulatory hemodilution therapy of peripheral arterial circulation disorders].
    Wohlleben E; Wohlleben H; Voigt H; Köhler H
    Z Gesamte Inn Med; 1981 Nov; 36(21):838-9. PubMed ID: 7331388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and instrumental evaluation of patients with chronic peripheral arterial occlusive disease after prolonged administration of suloctidil].
    Gregoratti L; Redaelli G; Limido P; Ghiringhelli L
    Clin Ter; 1982 Sep; 102(6):607-19. PubMed ID: 6291844
    [No Abstract]   [Full Text] [Related]  

  • 35. 6-Month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency.
    Bauer U
    Arzneimittelforschung; 1984; 34(6):716-20. PubMed ID: 6386008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Peripheral Arterial Occlusive Disease. Modern Therapeutic Principles (author's transl)].
    Hach W; Hach V
    MMW Munch Med Wochenschr; 1982 Mar; 124(10):234-8. PubMed ID: 6806610
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic hemodilution with middle molecular weight hydroxyethyl starch (Haes 200/0.62; 6 percent)].
    Jung F; Waldhausen P; Spitzer S; Mrowietz C; Häuser B; Wenzel E
    Infusionstherapie; 1988 Dec; 15(6):265-71. PubMed ID: 2466797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic consequences of hemorheologic research].
    Ernst E
    Wien Med Wochenschr; 1989 Dec; 139(24):569-80. PubMed ID: 2696217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Design and method of clinical trials of drugs used in the therapy of stable peripheral arterial occlusive disease].
    Wink K
    Arzneimittelforschung; 2006; 56(1):52-7. PubMed ID: 16478006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placebo-controlled, double-blind trial of hemodilution in peripheral occlusive arterial disease.
    Ernst E; Matrai A; Kollar L
    Angiology; 1989 May; 40(5):479-83. PubMed ID: 2468300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.